Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Ta bladder cancer with high risk of recurrence – fluorescence cystoscopy with optimized adjuvant mitomycin-C
2012-000559-15Phase 3Completed
- Sponsor
- FinnBladder
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of mitomycin c in bladder cancer (2 arms), sponsored by FinnBladder. Started Aug 2012; status: completed.
02
Drugs
mitomycin c
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2012-000559-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000559-15.